Industry News (Xenotransplantation)

Retrovirus Not Transmitted in Living Pig Tissue Transplantation

Published in Medical Letter on the CDC and FDA, August 30th, 1999

Evaluation of the largest-ever retrospective study to assess the safety of xenotransplantation shows there is no evidence of porcine endogenous retrovirus (PERV) infection in 160 patients previously treated with living pig tissue.

Reported in the August 19, 1999, issue of Science, the study was run by Imutran Ltd. (K. Paradis, et al., "Search for Cross-Species Transmission of Porcine Endogenous Retrovirus in Patients Treated with Living Pig Tissue," Science 1999;285:1236-1241).

"This study is an important milestone in the development of this potentially life-saving technology," said Dr. Corinne Savill, Imutran. "We hope in the long-term that this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-08-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry